Evaluation of an optimized intermittent vancomycin dosing regimen in infants
Our optimized vancomycin dosing regimen for infants aged 0-90 days achieved the target AUC24 in 88% and should be considered for routine use.
Authors
- Noel Cranswick (ORCID: https://orcid.org/0000-0002-6441-6561)
- Stephen B. Duffull (ORCID: https://orcid.org/0000-0002-6545-9408)
- Xiao Zhu (ORCID: https://orcid.org/0000-0003-3295-619X)
- Amanda L. Wilkins (ORCID: https://orcid.org/0000-0002-4265-1966)
- Amanda Gwee (ORCID: https://orcid.org/0000-0003-4016-8986)
- Wenyu Yang (ORCID: https://orcid.org/0000-0002-9057-4520)
- Nigel Curtis (ORCID: https://orcid.org/0000-0003-3446-4594)
Institutions
- Royal Children's Hospital (AU)
- The University of Melbourne (AU)
- Fudan University (CN)
- Government of New Zealand (NZ)
- Murdoch Children's Research Institute (AU)
- International Drug Development (FR)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-03-23
- DOI
- https://doi.org/10.1093/jac/dkaf112
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 0.00